Intellectual Property

Neugenesis' Intellectual Property is well protected as illustrated in the current patent portfolio that consists of four families of patents and patents pending.

MONOCLONAL ANTIBODY EXPRESSION

Heterologous Dimeric Proteins Produced in Heterokaryons
US Patent 5,643,745
Australia Patent 679,349
Europe EP 0 743 986 B1 (18 countries)
Korea 330038
Pending in Japan, Pending in Canada

GENE DIVERSIFICATION TECHNOLOGY

Single Gene Diversification
Filed in PCT/USA

Methods for Diversification of Heterologous DNA Sequences in Living Cells
US Patent 6,232,112

A Third Diversification Platform
In Preparation

COMBINATORIAL BIOLOGY

Methods and Composition for Combinatorial Based
US Patent 5,683,899

Discovery of New Multimeric Molecules
New Zealand 333,684
Allowed in Europe, Singapore

Combinatorial Metabolic Libraries
US Patent 6,268,140
Filed in PCT
EXPRESSION AND SCREENING
Neurospora Expression System
US Patent 5,695,965

Neurospora Hosts for the Production of Recombinant Proteins and Methods for Producing Same
US Patent 5,776,730
Singapore 9803368
Australia 721,592

Light-Regulated Promoters for Production of Heterologous Proteins in Filamentous Fungi
US Patent 5,741,665
Australia 700399

Production of Heterologous Peptides in Neurospora crassa (Glucoamylase Promoter)
US Patent 5,834,191
Australia 687852
Canada 2,169,377

Exploitation of the Cellulase Enzyme Complex of Neurospora
US Patent 5,955,270